Mitochondrial detachment of hexokinase 1 in mood and psychotic disorders: implications for brain energy metabolism and neurotrophic signaling.

[1]  Pierre J Magistretti,et al.  In Vivo Evidence for Lactate as a Neuronal Energy Source , 2011, The Journal of Neuroscience.

[2]  C. Konradi,et al.  Mitochondrial dysfunction and pathology in bipolar disorder and schizophrenia , 2011, International Journal of Developmental Neuroscience.

[3]  S. Dittmann,et al.  Cognitive abilities and clinical variables in bipolar I depressed and euthymic patients and controls. , 2011, Journal of Psychiatric Research.

[4]  Jesús Pujol,et al.  Cross-Sectional and Longitudinal Assessment of Structural Brain Alterations in Melancholic Depression , 2011, Biological Psychiatry.

[5]  W. Klein,et al.  Amyloid-β Triggers the Release of Neuronal Hexokinase 1 from Mitochondria , 2010, PloS one.

[6]  György Buzsáki,et al.  Predominant Enhancement of Glucose Uptake in Astrocytes versus Neurons during Activation of the Somatosensory Cortex , 2010, The Journal of Neuroscience.

[7]  S. Pizzo,et al.  Antibodies against the voltage-dependent anion channel (VDAC) and its protective ligand hexokinase-I in children with autism , 2010, Journal of Neuroimmunology.

[8]  J. Quevedo,et al.  Effects of mood stabilizers on mitochondrial respiratory chain activity in brain of rats treated with d-amphetamine. , 2010, Journal of psychiatric research.

[9]  M. Maj,et al.  Bipolar Disorder: Clinical and Neurobiological Foundations , 2010 .

[10]  M. Berk,et al.  Mitochondrial Dysfunction and Oxidative Stress , 2010 .

[11]  Anne E Carpenter,et al.  Abnormalities in mitochondrial structure in cells from patients with bipolar disorder. , 2010, The American journal of pathology.

[12]  Ann K. Shinn,et al.  Default mode network abnormalities in bipolar disorder and schizophrenia , 2010, Psychiatry Research: Neuroimaging.

[13]  H. Manji,et al.  Altered levels of extracellular signal-regulated kinase signaling proteins in postmortem frontal cortex of individuals with mood disorders and schizophrenia. , 2010, Journal of affective disorders.

[14]  J. Lieberman,et al.  Brain volumes in psychotic youth with schizophrenia and mood disorders. , 2010, Journal of psychiatry & neuroscience : JPN.

[15]  R. Myers,et al.  Mitochondrial Variants in Schizophrenia, Bipolar Disorder, and Major Depressive Disorder , 2009, PloS one.

[16]  R. Conley,et al.  Elevated Cerebrospinal Fluid Lactate Concentrations in Patients with Bipolar Disorder and Schizophrenia: Implications for the Mitochondrial Dysfunction Hypothesis , 2009, Biological Psychiatry.

[17]  R. Gullapalli,et al.  Relationship of cerebrospinal fluid glucose metabolites to MRI deep white matter hyperintensities and treatment resistance in bipolar disorder patients. , 2008, Bipolar disorders.

[18]  N. Sims,et al.  Isolation of mitochondria from rat brain using Percoll density gradient centrifugation , 2008, Nature Protocols.

[19]  Laura L. Vernon,et al.  Cognitive correlates of schizophrenia signs and symptoms: II. Emotional disturbances , 2008, Psychiatry Research.

[20]  T. Hansen,et al.  The estrogen hypothesis of Schizophrenia implicates glucose metabolism: Association study in three independent samples , 2008, BMC Medical Genetics.

[21]  C. Broeckhoven,et al.  Chromosome 10q harbors a susceptibility locus for bipolar disorder in Ashkenazi Jewish families , 2008, Molecular Psychiatry.

[22]  P. Fernyhough,et al.  Blockade of hexokinase activity and binding to mitochondria inhibits neurite outgrowth in cultured adult rat sensory neurons , 2008, Neuroscience Letters.

[23]  P. Mehta,et al.  Intranasal insulin improves cognition and modulates β-amyloid in early AD , 2008, Neurology.

[24]  H. Manji,et al.  Mitochondrially Mediated Plasticity in the Pathophysiology and Treatment of Bipolar Disorder , 2008, Neuropsychopharmacology.

[25]  R. Myers,et al.  Mitochondrial involvement in psychiatric disorders , 2008, Annals of medicine.

[26]  Jaskaran Singh,et al.  Regional Cerebral Glucose Metabolic Abnormalities in Bipolar II Depression , 2007, Biological Psychiatry.

[27]  O. Mors,et al.  A genome‐wide linkage search for bipolar disorder susceptibility loci in a large and complex pedigree from the eastern part of Cuba , 2006, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[28]  C. Sabatti,et al.  Convergent linkage evidence from two Latin-American population isolates supports the presence of a susceptibility locus for bipolar disorder in 5q31-34. , 2006, Human molecular genetics.

[29]  P. van Eerdewegh,et al.  Genome scan of Han Chinese schizophrenia families from Taiwan: confirmation of linkage to 10q22.3. , 2006, The American journal of psychiatry.

[30]  N. Hay,et al.  Mitochondrial hexokinases, novel mediators of the antiapoptotic effects of growth factors and Akt , 2006, Oncogene.

[31]  Elaine Holmes,et al.  Metabolic Profiling of CSF: Evidence That Early Intervention May Impact on Disease Progression and Outcome in Schizophrenia , 2006, PLoS medicine.

[32]  R. Myers,et al.  Mitochondrial-related gene expression changes are sensitive to agonal-pH state: implications for brain disorders , 2006, Molecular Psychiatry.

[33]  D. Butterfield,et al.  Adriamycin-induced, TNF-α-mediated central nervous system toxicity , 2006, Neurobiology of Disease.

[34]  Jun-Feng Wang,et al.  Downregulation in components of the mitochondrial electron transport chain in the postmortem frontal cortex of subjects with bipolar disorder. , 2006, Journal of psychiatry & neuroscience : JPN.

[35]  V. Haroutunian,et al.  Insulin receptor deficits in schizophrenia and in cellular and animal models of insulin receptor dysfunction , 2006, Schizophrenia Research.

[36]  Gary Christopher,et al.  The impact of clinical depression on working memory , 2005, Cognitive neuropsychiatry.

[37]  A. Schapira,et al.  Isolation of transcriptomal changes attributable to LHON mutations and the cybridization process. , 2005, Brain : a journal of neurology.

[38]  P. Hauser,et al.  Relationship of white matter hyperintensities to cerebrospinal fluid glucose polyol pathway metabolites-a pilot study in treatment-resistant affective disorder patients. , 2005, Journal of affective disorders.

[39]  N. Hay,et al.  Mitochondrial Hexokinases: Guardians of the Mitochondria , 2005, Cell cycle.

[40]  A. Verkhratsky,et al.  Insulin enhances mitochondrial inner membrane potential and increases ATP levels through phosphoinositide 3-kinase in adult sensory neurons , 2005, Molecular and Cellular Neuroscience.

[41]  Kazuya Iwamoto,et al.  Altered expression of mitochondria-related genes in postmortem brains of patients with bipolar disorder or schizophrenia, as revealed by large-scale DNA microarray analysis. , 2005, Human molecular genetics.

[42]  C. Thompson,et al.  Hexokinase-mitochondria interaction mediated by Akt is required to inhibit apoptosis in the presence or absence of Bax and Bak. , 2004, Molecular cell.

[43]  R. Moreno-Sánchez,et al.  Mitochondrial Bound Hexokinase Activity as a Preventive Antioxidant Defense , 2004, Journal of Biological Chemistry.

[44]  E T Bullmore,et al.  Reduced volume of parietal and frontal association areas in patients with schizophrenia characterized by passivity delusions , 2004, Psychological Medicine.

[45]  J. McGrath,et al.  Genomewide linkage scan for bipolar-disorder susceptibility loci among Ashkenazi Jewish families. , 2004, American journal of human genetics.

[46]  R. Yolken,et al.  Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress , 2004, Molecular Psychiatry.

[47]  Ming T Tsuang,et al.  Evidence for linkage between regulatory enzymes in glycolysis and schizophrenia in a multiplex sample , 2004, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[48]  M. Phelps,et al.  Acute changes in regional cerebral (18)F-FDG kinetics in patients with traumatic brain injury. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[49]  In Kyoon Lyoo,et al.  Brain metabolic alterations in medication-free patients with bipolar disorder. , 2004, Archives of general psychiatry.

[50]  P. Hauser,et al.  Post-mortem evidence from human brain tissue of disturbed glucose metabolism in mood and psychotic disorders , 2004, Molecular Psychiatry.

[51]  M. Erb,et al.  Parietal somatosensory association cortex mediates affective blindsight , 2004, Nature Neuroscience.

[52]  Huda Akil,et al.  Systematic changes in gene expression in postmortem human brains associated with tissue pH and terminal medical conditions. , 2004, Human molecular genetics.

[53]  Stephan Heckers,et al.  Molecular evidence for mitochondrial dysfunction in bipolar disorder. , 2004, Archives of general psychiatry.

[54]  N. Freimer,et al.  Genetic mapping using haplotype and model‐free linkage analysis supports previous evidence for a locus predisposing to severe bipolar disorder at 5q31‐33 , 2004, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[55]  M. Daly,et al.  Genome-wide scan in Portuguese Island families identifies 5q31–5q35 as a susceptibility locus for schizophrenia and psychosis , 2004, Molecular Psychiatry.

[56]  N. Kato,et al.  Reduced intracellular pH in the basal ganglia and whole brain measured by 31P‐MRS in bipolar disorder , 2004, Psychiatry and clinical neurosciences.

[57]  Jalal A Al-jamal.  Effect of different thyroid states on mitochondrial porin synthesis and hexokinase activity in developing rabbit brain. , 2004, Journal of biochemistry.

[58]  John Eric Wilson.  Isozymes of mammalian hexokinase: structure, subcellular localization and metabolic function , 2003, Journal of Experimental Biology.

[59]  Natalia Ojeda,et al.  Functional neuroanatomy of sustained attention in schizophrenia: Contribution of parietal cortices , 2002, Human brain mapping.

[60]  E. Kandel,et al.  Inhibition of early apoptotic events by Akt/PKB is dependent on the first committed step of glycolysis and mitochondrial hexokinase. , 2001, Genes & development.

[61]  A. Damasio,et al.  Subcortical and cortical brain activity during the feeling of self-generated emotions , 2000, Nature Neuroscience.

[62]  J B Poline,et al.  Working memory control in patients with schizophrenia: a PET study during a random number generation task. , 2000, The American journal of psychiatry.

[63]  N. Kato,et al.  Mitochondrial dysfunction in bipolar disorder. , 2000, Bipolar disorders.

[64]  F. Mechler,et al.  Cerebral blood flow and glucose metabolism in mitochondrial disorders , 2000, Neurology.

[65]  R. Yolken,et al.  The Stanley Foundation brain collection and Neuropathology Consortium , 2000, Schizophrenia Research.

[66]  P. Hauser,et al.  Elevated sorbitol concentration in the cerebrospinal fluid of patients with mood disorders , 2000, Psychoneuroendocrinology.

[67]  N. Kato,et al.  Association of bipolar disorder with the 5178 polymorphism in mitochondrial DNA. , 2000, American journal of medical genetics.

[68]  R. Roberts,et al.  Mitochondrial pathology in human schizophrenic striatum: a postmortem ultrastructural study , 1999 .

[69]  Edward E. Smith,et al.  The Role of Parietal Cortex in Verbal Working Memory , 1998, The Journal of Neuroscience.

[70]  F. McMahon,et al.  Increased levels of a mitochondrial DNA deletion in the brain of patients with bipolar disorder , 1997, Biological Psychiatry.

[71]  B. Dutrillaux,et al.  Intracellular pH governs the subcellular distribution of hexokinase in a glioma cell line. , 1996, The Biochemical journal.

[72]  J. Wilson,et al.  Application of a double isotopic labeling method to a study of the interaction of mitochondrially bound rat brain hexokinase with intramitochondrial compartments of ATP generated by oxidative phosphorylation. , 1995, Archives of biochemistry and biophysics.

[73]  B. Dutrillaux,et al.  Mitochondria‐bound hexokinase as target for therapy of malignant gliomas , 1995, International journal of cancer.

[74]  P. Magistretti,et al.  Glutamate uptake into astrocytes stimulates aerobic glycolysis: a mechanism coupling neuronal activity to glucose utilization. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[75]  André Luxen,et al.  Frontal and parietal metabolic disturbances in unipolar depression , 1994, Biological Psychiatry.

[76]  M. Hayden,et al.  Somatic and gonadal mosaicism of the Huntington disease gene CAG repeat in brain and sperm , 1994, Nature Genetics.

[77]  N. Arnheim,et al.  Mosaicism for a specific somatic mitochondrial DNA mutation in adult human brain , 1992, Nature Genetics.

[78]  John Eric Wilson,et al.  Coordinated regulation of cerebral glycolytic and oxidative metabolism, mediated by mitochondrially bound hexokinase dependent on intramitochondrially generated ATP. , 1992, Archives of biochemistry and biophysics.

[79]  R. Lynch,et al.  Modulation of hexokinase association with mitochondria analyzed with quantitative three-dimensional confocal microscopy , 1991, The Journal of cell biology.

[80]  C. Nahmias,et al.  Increased frontal and reduced parietal glucose metabolism in acute untreated schizophrenia , 1989, Psychiatry Research.

[81]  I. Silver,et al.  ATP and Brain Function , 1989, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[82]  S. Ohno,et al.  Three subtypes of chronic schizophrenia identified using 11C-glucose positron emission tomography , 1987, Psychiatry Research.

[83]  John Eric Wilson,et al.  Relative Levels of Hexokinase in Isolated Neuronal, Astrocytic, and Oligodendroglial Fractions from Rat Brain , 1983, Journal of neurochemistry.

[84]  H. Jörnvall,et al.  Enzyme relationships in a sorbitol pathway that bypasses glycolysis and pentose phosphates in glucose metabolism. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[85]  N. Baquer,et al.  Hexokinase isoenzymes in diabetes , 1980, Journal of Biosciences.

[86]  J J Bartko,et al.  Signs and symptoms as predictors of outcome: a report from the International Pilot Study of Schizophrenia. , 1978, The American journal of psychiatry.

[87]  R. Berger,et al.  Development of mitochondrial energy metabolism in rat brain. , 1977, The Biochemical journal.

[88]  H. Knull,et al.  Insulin effects on brain energy metabolism and the related hexokinase distribution. , 1974, The Journal of biological chemistry.

[89]  K. Gabbay,et al.  Sorbitol Pathway: Presence in Nerve and Cord with Substrate Accumulation in Diabetes , 1966, Science.

[90]  A. Sols,et al.  The association of hexokinase with particulate fractions of brain and other tissue homogenates. , 1953, The Journal of biological chemistry.

[91]  Jan Hutny,et al.  Further studies on the role of phospholipids in determining the characteristics of mitochondrial binding sites for type I hexokinase. , 2000, Acta biochimica Polonica.